Assetmark »

Bicycle Therapeutics shares owned by Assetmark

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by Assetmark

Quarter filed Position value Share count Share price at filing
2024-09-30 $34k 1.5k 22.63

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Core S&p500 Etf (IVV)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Assetmark

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Deep Track Capital
RA Capital Management
Fcpm Iii Services B.v.
Armistice Capital
Westfield Capital Management Company
T. Rowe Price Associates
Morgan Stanley
First Light Asset Management
EcoR1 Capital
Point72 Asset Management
Bnp Paribas Investment Partners
Candriam Luxembourg S.C.A.
Parkman Healthcare Partners
Principal Financial Group

View all funds holding Bicycle Therapeutics